nodes	percent_of_prediction	percent_of_DWPC	metapath
Reboxetine—Orphenadrine—Tamoxifen—pancreatic cancer	0.243	0.53	CrCrCtD
Reboxetine—Diphenhydramine—Tamoxifen—pancreatic cancer	0.215	0.47	CrCrCtD
Reboxetine—ABCB1—Tamoxifen—pancreatic cancer	0.0359	0.104	CbGbCtD
Reboxetine—CYP2D6—Tamoxifen—pancreatic cancer	0.0338	0.0976	CbGbCtD
Reboxetine—ABCB1—Gemcitabine—pancreatic cancer	0.0309	0.0892	CbGbCtD
Reboxetine—ABCB1—Erlotinib—pancreatic cancer	0.0305	0.0881	CbGbCtD
Reboxetine—CYP2D6—Erlotinib—pancreatic cancer	0.0288	0.083	CbGbCtD
Reboxetine—ABCB1—Irinotecan—pancreatic cancer	0.0276	0.0795	CbGbCtD
Reboxetine—CYP3A4—Tamoxifen—pancreatic cancer	0.0215	0.0621	CbGbCtD
Reboxetine—ABCB1—Docetaxel—pancreatic cancer	0.0202	0.0583	CbGbCtD
Reboxetine—ABCB1—Sunitinib—pancreatic cancer	0.0201	0.058	CbGbCtD
Reboxetine—CYP3A4—Erlotinib—pancreatic cancer	0.0183	0.0528	CbGbCtD
Reboxetine—CYP3A4—Irinotecan—pancreatic cancer	0.0165	0.0477	CbGbCtD
Reboxetine—ABCB1—Doxorubicin—pancreatic cancer	0.0151	0.0435	CbGbCtD
Reboxetine—CYP2D6—Doxorubicin—pancreatic cancer	0.0142	0.0409	CbGbCtD
Reboxetine—CYP3A4—Docetaxel—pancreatic cancer	0.0121	0.0349	CbGbCtD
Reboxetine—CYP3A4—Sunitinib—pancreatic cancer	0.012	0.0348	CbGbCtD
Reboxetine—CYP3A4—Doxorubicin—pancreatic cancer	0.00902	0.026	CbGbCtD
Reboxetine—Nausea—Tamoxifen—pancreatic cancer	0.000205	0.00105	CcSEcCtD
Reboxetine—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.000205	0.00105	CcSEcCtD
Reboxetine—Alanine aminotransferase increased—Epirubicin—pancreatic cancer	0.000204	0.00104	CcSEcCtD
Reboxetine—Muscular weakness—Epirubicin—pancreatic cancer	0.000204	0.00104	CcSEcCtD
Reboxetine—Constipation—Gemcitabine—pancreatic cancer	0.000203	0.00104	CcSEcCtD
Reboxetine—Nausea—Erlotinib—pancreatic cancer	0.000203	0.00104	CcSEcCtD
Reboxetine—Decreased appetite—Fluorouracil—pancreatic cancer	0.000203	0.00104	CcSEcCtD
Reboxetine—Diarrhoea—Sunitinib—pancreatic cancer	0.000202	0.00103	CcSEcCtD
Reboxetine—Dysgeusia—Docetaxel—pancreatic cancer	0.000202	0.00103	CcSEcCtD
Reboxetine—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.000201	0.00103	CcSEcCtD
Reboxetine—Feeling abnormal—Irinotecan—pancreatic cancer	0.000201	0.00103	CcSEcCtD
Reboxetine—Blood creatinine increased—Doxorubicin—pancreatic cancer	0.0002	0.00102	CcSEcCtD
Reboxetine—Influenza—Epirubicin—pancreatic cancer	0.0002	0.00102	CcSEcCtD
Reboxetine—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.000199	0.00102	CcSEcCtD
Reboxetine—Dehydration—Doxorubicin—pancreatic cancer	0.000199	0.00102	CcSEcCtD
Reboxetine—Liver function test abnormal—Doxorubicin—pancreatic cancer	0.000197	0.00101	CcSEcCtD
Reboxetine—Dizziness—Sunitinib—pancreatic cancer	0.000196	0.001	CcSEcCtD
Reboxetine—Feeling abnormal—Gemcitabine—pancreatic cancer	0.000196	0.001	CcSEcCtD
Reboxetine—Orthostatic hypotension—Doxorubicin—pancreatic cancer	0.000195	0.000998	CcSEcCtD
Reboxetine—Breast disorder—Doxorubicin—pancreatic cancer	0.000193	0.000988	CcSEcCtD
Reboxetine—Abdominal pain—Irinotecan—pancreatic cancer	0.000193	0.000984	CcSEcCtD
Reboxetine—Body temperature increased—Irinotecan—pancreatic cancer	0.000193	0.000984	CcSEcCtD
Reboxetine—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000192	0.000983	CcSEcCtD
Reboxetine—Bronchitis—Epirubicin—pancreatic cancer	0.000192	0.000982	CcSEcCtD
Reboxetine—Anaemia—Docetaxel—pancreatic cancer	0.000191	0.000975	CcSEcCtD
Reboxetine—Muscular weakness—Doxorubicin—pancreatic cancer	0.000189	0.000964	CcSEcCtD
Reboxetine—Alanine aminotransferase increased—Doxorubicin—pancreatic cancer	0.000189	0.000964	CcSEcCtD
Reboxetine—Vomiting—Sunitinib—pancreatic cancer	0.000188	0.000961	CcSEcCtD
Reboxetine—Body temperature increased—Gemcitabine—pancreatic cancer	0.000188	0.000959	CcSEcCtD
Reboxetine—Dysuria—Epirubicin—pancreatic cancer	0.000187	0.000955	CcSEcCtD
Reboxetine—Rash—Sunitinib—pancreatic cancer	0.000186	0.000953	CcSEcCtD
Reboxetine—Dermatitis—Sunitinib—pancreatic cancer	0.000186	0.000952	CcSEcCtD
Reboxetine—Urticaria—Fluorouracil—pancreatic cancer	0.000185	0.000948	CcSEcCtD
Reboxetine—Headache—Sunitinib—pancreatic cancer	0.000185	0.000947	CcSEcCtD
Reboxetine—Syncope—Docetaxel—pancreatic cancer	0.000185	0.000946	CcSEcCtD
Reboxetine—Influenza—Doxorubicin—pancreatic cancer	0.000185	0.000945	CcSEcCtD
Reboxetine—Leukopenia—Docetaxel—pancreatic cancer	0.000185	0.000944	CcSEcCtD
Reboxetine—Pollakiuria—Epirubicin—pancreatic cancer	0.000185	0.000943	CcSEcCtD
Reboxetine—Body temperature increased—Fluorouracil—pancreatic cancer	0.000184	0.000943	CcSEcCtD
Reboxetine—Palpitations—Docetaxel—pancreatic cancer	0.000182	0.000932	CcSEcCtD
Reboxetine—Loss of consciousness—Docetaxel—pancreatic cancer	0.000181	0.000927	CcSEcCtD
Reboxetine—Weight decreased—Epirubicin—pancreatic cancer	0.000181	0.000924	CcSEcCtD
Reboxetine—Hyperglycaemia—Epirubicin—pancreatic cancer	0.00018	0.000921	CcSEcCtD
Reboxetine—Hypersensitivity—Irinotecan—pancreatic cancer	0.000179	0.000918	CcSEcCtD
Reboxetine—Hypertension—Docetaxel—pancreatic cancer	0.000178	0.000911	CcSEcCtD
Reboxetine—Infestation NOS—Epirubicin—pancreatic cancer	0.000178	0.00091	CcSEcCtD
Reboxetine—Infestation—Epirubicin—pancreatic cancer	0.000178	0.00091	CcSEcCtD
Reboxetine—Bronchitis—Doxorubicin—pancreatic cancer	0.000178	0.000909	CcSEcCtD
Reboxetine—Chest pain—Docetaxel—pancreatic cancer	0.000176	0.000898	CcSEcCtD
Reboxetine—Nausea—Sunitinib—pancreatic cancer	0.000176	0.000898	CcSEcCtD
Reboxetine—Asthenia—Irinotecan—pancreatic cancer	0.000175	0.000894	CcSEcCtD
Reboxetine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000174	0.000892	CcSEcCtD
Reboxetine—Urinary tract infection—Epirubicin—pancreatic cancer	0.000173	0.000885	CcSEcCtD
Reboxetine—Conjunctivitis—Epirubicin—pancreatic cancer	0.000173	0.000885	CcSEcCtD
Reboxetine—Dysuria—Doxorubicin—pancreatic cancer	0.000173	0.000883	CcSEcCtD
Reboxetine—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000172	0.000879	CcSEcCtD
Reboxetine—Dry mouth—Docetaxel—pancreatic cancer	0.000172	0.000878	CcSEcCtD
Reboxetine—Sweating—Epirubicin—pancreatic cancer	0.000171	0.000873	CcSEcCtD
Reboxetine—Pollakiuria—Doxorubicin—pancreatic cancer	0.000171	0.000873	CcSEcCtD
Reboxetine—Asthenia—Gemcitabine—pancreatic cancer	0.00017	0.00087	CcSEcCtD
Reboxetine—Confusional state—Docetaxel—pancreatic cancer	0.00017	0.000868	CcSEcCtD
Reboxetine—Epistaxis—Epirubicin—pancreatic cancer	0.000168	0.000859	CcSEcCtD
Reboxetine—Infection—Docetaxel—pancreatic cancer	0.000167	0.000855	CcSEcCtD
Reboxetine—Weight decreased—Doxorubicin—pancreatic cancer	0.000167	0.000855	CcSEcCtD
Reboxetine—Sinusitis—Epirubicin—pancreatic cancer	0.000167	0.000854	CcSEcCtD
Reboxetine—Hyperglycaemia—Doxorubicin—pancreatic cancer	0.000167	0.000852	CcSEcCtD
Reboxetine—Diarrhoea—Irinotecan—pancreatic cancer	0.000167	0.000852	CcSEcCtD
Reboxetine—Shock—Docetaxel—pancreatic cancer	0.000166	0.000847	CcSEcCtD
Reboxetine—Nervous system disorder—Docetaxel—pancreatic cancer	0.000165	0.000844	CcSEcCtD
Reboxetine—Infestation NOS—Doxorubicin—pancreatic cancer	0.000165	0.000842	CcSEcCtD
Reboxetine—Infestation—Doxorubicin—pancreatic cancer	0.000165	0.000842	CcSEcCtD
Reboxetine—Tachycardia—Docetaxel—pancreatic cancer	0.000164	0.00084	CcSEcCtD
Reboxetine—Skin disorder—Docetaxel—pancreatic cancer	0.000164	0.000836	CcSEcCtD
Reboxetine—Bradycardia—Epirubicin—pancreatic cancer	0.000163	0.000832	CcSEcCtD
Reboxetine—Diarrhoea—Gemcitabine—pancreatic cancer	0.000162	0.00083	CcSEcCtD
Reboxetine—Dizziness—Irinotecan—pancreatic cancer	0.000161	0.000824	CcSEcCtD
Reboxetine—Anorexia—Docetaxel—pancreatic cancer	0.000161	0.000821	CcSEcCtD
Reboxetine—Rhinitis—Epirubicin—pancreatic cancer	0.00016	0.000819	CcSEcCtD
Reboxetine—Conjunctivitis—Doxorubicin—pancreatic cancer	0.00016	0.000819	CcSEcCtD
Reboxetine—Urinary tract infection—Doxorubicin—pancreatic cancer	0.00016	0.000819	CcSEcCtD
Reboxetine—Diarrhoea—Fluorouracil—pancreatic cancer	0.00016	0.000816	CcSEcCtD
Reboxetine—Pharyngitis—Epirubicin—pancreatic cancer	0.000159	0.000811	CcSEcCtD
Reboxetine—Sweating—Doxorubicin—pancreatic cancer	0.000158	0.000808	CcSEcCtD
Reboxetine—Urinary tract disorder—Epirubicin—pancreatic cancer	0.000158	0.000807	CcSEcCtD
Reboxetine—Hypotension—Docetaxel—pancreatic cancer	0.000157	0.000804	CcSEcCtD
Reboxetine—Connective tissue disorder—Epirubicin—pancreatic cancer	0.000157	0.000803	CcSEcCtD
Reboxetine—Urethral disorder—Epirubicin—pancreatic cancer	0.000157	0.000801	CcSEcCtD
Reboxetine—Epistaxis—Doxorubicin—pancreatic cancer	0.000155	0.000795	CcSEcCtD
Reboxetine—Vomiting—Irinotecan—pancreatic cancer	0.000155	0.000792	CcSEcCtD
Reboxetine—Sinusitis—Doxorubicin—pancreatic cancer	0.000155	0.00079	CcSEcCtD
Reboxetine—Dizziness—Fluorouracil—pancreatic cancer	0.000154	0.000789	CcSEcCtD
Reboxetine—Visual impairment—Epirubicin—pancreatic cancer	0.000154	0.000788	CcSEcCtD
Reboxetine—Rash—Irinotecan—pancreatic cancer	0.000154	0.000785	CcSEcCtD
Reboxetine—Dermatitis—Irinotecan—pancreatic cancer	0.000153	0.000784	CcSEcCtD
Reboxetine—Headache—Irinotecan—pancreatic cancer	0.000153	0.00078	CcSEcCtD
Reboxetine—Insomnia—Docetaxel—pancreatic cancer	0.000152	0.000779	CcSEcCtD
Reboxetine—Paraesthesia—Docetaxel—pancreatic cancer	0.000151	0.000773	CcSEcCtD
Reboxetine—Vomiting—Gemcitabine—pancreatic cancer	0.000151	0.000771	CcSEcCtD
Reboxetine—Bradycardia—Doxorubicin—pancreatic cancer	0.000151	0.00077	CcSEcCtD
Reboxetine—Dyspnoea—Docetaxel—pancreatic cancer	0.00015	0.000768	CcSEcCtD
Reboxetine—Somnolence—Docetaxel—pancreatic cancer	0.00015	0.000765	CcSEcCtD
Reboxetine—Rash—Gemcitabine—pancreatic cancer	0.00015	0.000765	CcSEcCtD
Reboxetine—Dermatitis—Gemcitabine—pancreatic cancer	0.000149	0.000764	CcSEcCtD
Reboxetine—Eye disorder—Epirubicin—pancreatic cancer	0.000149	0.000764	CcSEcCtD
Reboxetine—Tinnitus—Epirubicin—pancreatic cancer	0.000149	0.000762	CcSEcCtD
Reboxetine—Headache—Gemcitabine—pancreatic cancer	0.000149	0.00076	CcSEcCtD
Reboxetine—Cardiac disorder—Epirubicin—pancreatic cancer	0.000148	0.000759	CcSEcCtD
Reboxetine—Vomiting—Fluorouracil—pancreatic cancer	0.000148	0.000758	CcSEcCtD
Reboxetine—Rhinitis—Doxorubicin—pancreatic cancer	0.000148	0.000758	CcSEcCtD
Reboxetine—Dyspepsia—Docetaxel—pancreatic cancer	0.000148	0.000758	CcSEcCtD
Reboxetine—Rash—Fluorouracil—pancreatic cancer	0.000147	0.000752	CcSEcCtD
Reboxetine—Dermatitis—Fluorouracil—pancreatic cancer	0.000147	0.000751	CcSEcCtD
Reboxetine—Pharyngitis—Doxorubicin—pancreatic cancer	0.000147	0.000751	CcSEcCtD
Reboxetine—Decreased appetite—Docetaxel—pancreatic cancer	0.000146	0.000748	CcSEcCtD
Reboxetine—Headache—Fluorouracil—pancreatic cancer	0.000146	0.000747	CcSEcCtD
Reboxetine—Urinary tract disorder—Doxorubicin—pancreatic cancer	0.000146	0.000747	CcSEcCtD
Reboxetine—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000145	0.000743	CcSEcCtD
Reboxetine—Connective tissue disorder—Doxorubicin—pancreatic cancer	0.000145	0.000743	CcSEcCtD
Reboxetine—Angiopathy—Epirubicin—pancreatic cancer	0.000145	0.000742	CcSEcCtD
Reboxetine—Urethral disorder—Doxorubicin—pancreatic cancer	0.000145	0.000741	CcSEcCtD
Reboxetine—Nausea—Irinotecan—pancreatic cancer	0.000145	0.00074	CcSEcCtD
Reboxetine—Immune system disorder—Epirubicin—pancreatic cancer	0.000144	0.000738	CcSEcCtD
Reboxetine—Mediastinal disorder—Epirubicin—pancreatic cancer	0.000144	0.000737	CcSEcCtD
Reboxetine—Constipation—Docetaxel—pancreatic cancer	0.000144	0.000736	CcSEcCtD
Reboxetine—Chills—Epirubicin—pancreatic cancer	0.000143	0.000733	CcSEcCtD
Reboxetine—Visual impairment—Doxorubicin—pancreatic cancer	0.000143	0.000729	CcSEcCtD
Reboxetine—Nausea—Gemcitabine—pancreatic cancer	0.000141	0.000721	CcSEcCtD
Reboxetine—Mental disorder—Epirubicin—pancreatic cancer	0.00014	0.000716	CcSEcCtD
Reboxetine—Malnutrition—Epirubicin—pancreatic cancer	0.000139	0.000711	CcSEcCtD
Reboxetine—Feeling abnormal—Docetaxel—pancreatic cancer	0.000139	0.000709	CcSEcCtD
Reboxetine—Nausea—Fluorouracil—pancreatic cancer	0.000139	0.000708	CcSEcCtD
Reboxetine—Eye disorder—Doxorubicin—pancreatic cancer	0.000138	0.000707	CcSEcCtD
Reboxetine—Tinnitus—Doxorubicin—pancreatic cancer	0.000138	0.000705	CcSEcCtD
Reboxetine—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000138	0.000704	CcSEcCtD
Reboxetine—Cardiac disorder—Doxorubicin—pancreatic cancer	0.000137	0.000702	CcSEcCtD
Reboxetine—Tension—Epirubicin—pancreatic cancer	0.000137	0.000698	CcSEcCtD
Reboxetine—Dysgeusia—Epirubicin—pancreatic cancer	0.000136	0.000697	CcSEcCtD
Reboxetine—Nervousness—Epirubicin—pancreatic cancer	0.000135	0.000691	CcSEcCtD
Reboxetine—Angiopathy—Doxorubicin—pancreatic cancer	0.000134	0.000686	CcSEcCtD
Reboxetine—Immune system disorder—Doxorubicin—pancreatic cancer	0.000134	0.000683	CcSEcCtD
Reboxetine—Mediastinal disorder—Doxorubicin—pancreatic cancer	0.000133	0.000682	CcSEcCtD
Reboxetine—Body temperature increased—Docetaxel—pancreatic cancer	0.000133	0.000681	CcSEcCtD
Reboxetine—Abdominal pain—Docetaxel—pancreatic cancer	0.000133	0.000681	CcSEcCtD
Reboxetine—Chills—Doxorubicin—pancreatic cancer	0.000133	0.000679	CcSEcCtD
Reboxetine—Mental disorder—Doxorubicin—pancreatic cancer	0.00013	0.000663	CcSEcCtD
Reboxetine—Ill-defined disorder—Epirubicin—pancreatic cancer	0.000129	0.00066	CcSEcCtD
Reboxetine—Malnutrition—Doxorubicin—pancreatic cancer	0.000129	0.000658	CcSEcCtD
Reboxetine—Anaemia—Epirubicin—pancreatic cancer	0.000129	0.000658	CcSEcCtD
Reboxetine—Agitation—Epirubicin—pancreatic cancer	0.000128	0.000654	CcSEcCtD
Reboxetine—Tension—Doxorubicin—pancreatic cancer	0.000126	0.000646	CcSEcCtD
Reboxetine—Dysgeusia—Doxorubicin—pancreatic cancer	0.000126	0.000645	CcSEcCtD
Reboxetine—Malaise—Epirubicin—pancreatic cancer	0.000126	0.000642	CcSEcCtD
Reboxetine—Nervousness—Doxorubicin—pancreatic cancer	0.000125	0.000639	CcSEcCtD
Reboxetine—Vertigo—Epirubicin—pancreatic cancer	0.000125	0.000639	CcSEcCtD
Reboxetine—Syncope—Epirubicin—pancreatic cancer	0.000125	0.000638	CcSEcCtD
Reboxetine—Leukopenia—Epirubicin—pancreatic cancer	0.000125	0.000637	CcSEcCtD
Reboxetine—Hypersensitivity—Docetaxel—pancreatic cancer	0.000124	0.000634	CcSEcCtD
Reboxetine—Palpitations—Epirubicin—pancreatic cancer	0.000123	0.000629	CcSEcCtD
Reboxetine—Loss of consciousness—Epirubicin—pancreatic cancer	0.000122	0.000625	CcSEcCtD
Reboxetine—Asthenia—Docetaxel—pancreatic cancer	0.000121	0.000618	CcSEcCtD
Reboxetine—Hypertension—Epirubicin—pancreatic cancer	0.00012	0.000614	CcSEcCtD
Reboxetine—Ill-defined disorder—Doxorubicin—pancreatic cancer	0.000119	0.000611	CcSEcCtD
Reboxetine—Anaemia—Doxorubicin—pancreatic cancer	0.000119	0.000608	CcSEcCtD
Reboxetine—Chest pain—Epirubicin—pancreatic cancer	0.000118	0.000606	CcSEcCtD
Reboxetine—Agitation—Doxorubicin—pancreatic cancer	0.000118	0.000605	CcSEcCtD
Reboxetine—Anxiety—Epirubicin—pancreatic cancer	0.000118	0.000604	CcSEcCtD
Reboxetine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.000118	0.000602	CcSEcCtD
Reboxetine—Discomfort—Epirubicin—pancreatic cancer	0.000117	0.000598	CcSEcCtD
Reboxetine—Malaise—Doxorubicin—pancreatic cancer	0.000116	0.000594	CcSEcCtD
Reboxetine—Dry mouth—Epirubicin—pancreatic cancer	0.000116	0.000592	CcSEcCtD
Reboxetine—Vertigo—Doxorubicin—pancreatic cancer	0.000116	0.000591	CcSEcCtD
Reboxetine—Syncope—Doxorubicin—pancreatic cancer	0.000115	0.00059	CcSEcCtD
Reboxetine—Leukopenia—Doxorubicin—pancreatic cancer	0.000115	0.000589	CcSEcCtD
Reboxetine—Diarrhoea—Docetaxel—pancreatic cancer	0.000115	0.000589	CcSEcCtD
Reboxetine—Confusional state—Epirubicin—pancreatic cancer	0.000115	0.000585	CcSEcCtD
Reboxetine—Palpitations—Doxorubicin—pancreatic cancer	0.000114	0.000582	CcSEcCtD
Reboxetine—Loss of consciousness—Doxorubicin—pancreatic cancer	0.000113	0.000579	CcSEcCtD
Reboxetine—Infection—Epirubicin—pancreatic cancer	0.000113	0.000577	CcSEcCtD
Reboxetine—Shock—Epirubicin—pancreatic cancer	0.000112	0.000571	CcSEcCtD
Reboxetine—Nervous system disorder—Epirubicin—pancreatic cancer	0.000111	0.000569	CcSEcCtD
Reboxetine—Dizziness—Docetaxel—pancreatic cancer	0.000111	0.000569	CcSEcCtD
Reboxetine—Hypertension—Doxorubicin—pancreatic cancer	0.000111	0.000568	CcSEcCtD
Reboxetine—Tachycardia—Epirubicin—pancreatic cancer	0.000111	0.000567	CcSEcCtD
Reboxetine—Skin disorder—Epirubicin—pancreatic cancer	0.00011	0.000564	CcSEcCtD
Reboxetine—Hyperhidrosis—Epirubicin—pancreatic cancer	0.00011	0.000561	CcSEcCtD
Reboxetine—Chest pain—Doxorubicin—pancreatic cancer	0.00011	0.00056	CcSEcCtD
Reboxetine—Anxiety—Doxorubicin—pancreatic cancer	0.000109	0.000559	CcSEcCtD
Reboxetine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.000109	0.000557	CcSEcCtD
Reboxetine—Discomfort—Doxorubicin—pancreatic cancer	0.000108	0.000554	CcSEcCtD
Reboxetine—Anorexia—Epirubicin—pancreatic cancer	0.000108	0.000553	CcSEcCtD
Reboxetine—Dry mouth—Doxorubicin—pancreatic cancer	0.000107	0.000548	CcSEcCtD
Reboxetine—Vomiting—Docetaxel—pancreatic cancer	0.000107	0.000547	CcSEcCtD
Reboxetine—Rash—Docetaxel—pancreatic cancer	0.000106	0.000543	CcSEcCtD
Reboxetine—Hypotension—Epirubicin—pancreatic cancer	0.000106	0.000543	CcSEcCtD
Reboxetine—Dermatitis—Docetaxel—pancreatic cancer	0.000106	0.000542	CcSEcCtD
Reboxetine—Confusional state—Doxorubicin—pancreatic cancer	0.000106	0.000542	CcSEcCtD
Reboxetine—Headache—Docetaxel—pancreatic cancer	0.000105	0.000539	CcSEcCtD
Reboxetine—Infection—Doxorubicin—pancreatic cancer	0.000104	0.000534	CcSEcCtD
Reboxetine—Shock—Doxorubicin—pancreatic cancer	0.000103	0.000529	CcSEcCtD
Reboxetine—Nervous system disorder—Doxorubicin—pancreatic cancer	0.000103	0.000527	CcSEcCtD
Reboxetine—Insomnia—Epirubicin—pancreatic cancer	0.000103	0.000525	CcSEcCtD
Reboxetine—Tachycardia—Doxorubicin—pancreatic cancer	0.000103	0.000524	CcSEcCtD
Reboxetine—Skin disorder—Doxorubicin—pancreatic cancer	0.000102	0.000522	CcSEcCtD
Reboxetine—Paraesthesia—Epirubicin—pancreatic cancer	0.000102	0.000521	CcSEcCtD
Reboxetine—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.000102	0.000519	CcSEcCtD
Reboxetine—Dyspnoea—Epirubicin—pancreatic cancer	0.000101	0.000518	CcSEcCtD
Reboxetine—Somnolence—Epirubicin—pancreatic cancer	0.000101	0.000516	CcSEcCtD
Reboxetine—Anorexia—Doxorubicin—pancreatic cancer	0.0001	0.000512	CcSEcCtD
Reboxetine—Nausea—Docetaxel—pancreatic cancer	0.0001	0.000511	CcSEcCtD
Reboxetine—Dyspepsia—Epirubicin—pancreatic cancer	0.0001	0.000511	CcSEcCtD
Reboxetine—Decreased appetite—Epirubicin—pancreatic cancer	9.87e-05	0.000505	CcSEcCtD
Reboxetine—Hypotension—Doxorubicin—pancreatic cancer	9.82e-05	0.000502	CcSEcCtD
Reboxetine—Gastrointestinal disorder—Epirubicin—pancreatic cancer	9.81e-05	0.000501	CcSEcCtD
Reboxetine—Constipation—Epirubicin—pancreatic cancer	9.71e-05	0.000497	CcSEcCtD
Reboxetine—Insomnia—Doxorubicin—pancreatic cancer	9.51e-05	0.000486	CcSEcCtD
Reboxetine—Paraesthesia—Doxorubicin—pancreatic cancer	9.44e-05	0.000482	CcSEcCtD
Reboxetine—Dyspnoea—Doxorubicin—pancreatic cancer	9.37e-05	0.000479	CcSEcCtD
Reboxetine—Feeling abnormal—Epirubicin—pancreatic cancer	9.36e-05	0.000478	CcSEcCtD
Reboxetine—Somnolence—Doxorubicin—pancreatic cancer	9.34e-05	0.000478	CcSEcCtD
Reboxetine—Gastrointestinal pain—Epirubicin—pancreatic cancer	9.29e-05	0.000475	CcSEcCtD
Reboxetine—Dyspepsia—Doxorubicin—pancreatic cancer	9.25e-05	0.000473	CcSEcCtD
Reboxetine—Decreased appetite—Doxorubicin—pancreatic cancer	9.14e-05	0.000467	CcSEcCtD
Reboxetine—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	9.07e-05	0.000464	CcSEcCtD
Reboxetine—Urticaria—Epirubicin—pancreatic cancer	9.02e-05	0.000461	CcSEcCtD
Reboxetine—Constipation—Doxorubicin—pancreatic cancer	8.99e-05	0.000459	CcSEcCtD
Reboxetine—Abdominal pain—Epirubicin—pancreatic cancer	8.98e-05	0.000459	CcSEcCtD
Reboxetine—Body temperature increased—Epirubicin—pancreatic cancer	8.98e-05	0.000459	CcSEcCtD
Reboxetine—Feeling abnormal—Doxorubicin—pancreatic cancer	8.66e-05	0.000443	CcSEcCtD
Reboxetine—Gastrointestinal pain—Doxorubicin—pancreatic cancer	8.59e-05	0.000439	CcSEcCtD
Reboxetine—Hypersensitivity—Epirubicin—pancreatic cancer	8.37e-05	0.000428	CcSEcCtD
Reboxetine—Urticaria—Doxorubicin—pancreatic cancer	8.35e-05	0.000427	CcSEcCtD
Reboxetine—Abdominal pain—Doxorubicin—pancreatic cancer	8.31e-05	0.000425	CcSEcCtD
Reboxetine—Body temperature increased—Doxorubicin—pancreatic cancer	8.31e-05	0.000425	CcSEcCtD
Reboxetine—Asthenia—Epirubicin—pancreatic cancer	8.15e-05	0.000417	CcSEcCtD
Reboxetine—Diarrhoea—Epirubicin—pancreatic cancer	7.77e-05	0.000397	CcSEcCtD
Reboxetine—Hypersensitivity—Doxorubicin—pancreatic cancer	7.74e-05	0.000396	CcSEcCtD
Reboxetine—Asthenia—Doxorubicin—pancreatic cancer	7.54e-05	0.000385	CcSEcCtD
Reboxetine—Dizziness—Epirubicin—pancreatic cancer	7.51e-05	0.000384	CcSEcCtD
Reboxetine—Vomiting—Epirubicin—pancreatic cancer	7.22e-05	0.000369	CcSEcCtD
Reboxetine—Diarrhoea—Doxorubicin—pancreatic cancer	7.19e-05	0.000368	CcSEcCtD
Reboxetine—Rash—Epirubicin—pancreatic cancer	7.16e-05	0.000366	CcSEcCtD
Reboxetine—Dermatitis—Epirubicin—pancreatic cancer	7.15e-05	0.000366	CcSEcCtD
Reboxetine—Headache—Epirubicin—pancreatic cancer	7.12e-05	0.000364	CcSEcCtD
Reboxetine—Dizziness—Doxorubicin—pancreatic cancer	6.95e-05	0.000355	CcSEcCtD
Reboxetine—Nausea—Epirubicin—pancreatic cancer	6.75e-05	0.000345	CcSEcCtD
Reboxetine—Vomiting—Doxorubicin—pancreatic cancer	6.68e-05	0.000342	CcSEcCtD
Reboxetine—Rash—Doxorubicin—pancreatic cancer	6.63e-05	0.000339	CcSEcCtD
Reboxetine—Dermatitis—Doxorubicin—pancreatic cancer	6.62e-05	0.000338	CcSEcCtD
Reboxetine—Headache—Doxorubicin—pancreatic cancer	6.58e-05	0.000337	CcSEcCtD
Reboxetine—Nausea—Doxorubicin—pancreatic cancer	6.24e-05	0.000319	CcSEcCtD
